Skip to main content
Caplight Logo









Glaia

Glaia

Private
BristolHealthcare & Life Scienceshttps://glaia.co.uk

Last Round

Seed

Mar 1, 2022

Total Funding Raised

$1.76M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Glaia operates in Healthcare & Life Sciences and is based in Bristol. Its latest recorded funding round was a Seed round in March 2022.

Glaia is an agricultural technology company that develops nanotechnology-based biostimulants designed to enhance the efficiency of photosynthesis and increase crop yields.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Glaia Comparables

Compare Glaia with similar companies based on industry and business-model similarity.

Glaia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SugaROx
79%
ONIT Holdings
76%
Lambda Agri
70%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Glaia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 1, 2022
GrantSep 1, 2020
AcceleratorJun 24, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

David Benito-Alifonso

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Glaia Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 38% MoM, reaching 1K.

  • Mar 1, 2022

    $1.3M round led by Green Angel Syndicate and Green Angel Ventures.

Book a demo to see all signals

For institutional investors. Book with your work email.

Glaia Filings

Explore SEC and related filing metadata, where available.

Glaia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Glaia's valuation, stock price, and market status.

Is Glaia a public or private company?

Glaia is a private company.

What is the current stock price of Glaia?

Glaia is a private company, so its shares have no public market price. Caplight tracks Glaia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Glaia worth (valuation)?

Valuation information for Glaia is not publicly available.

Can I buy Glaia stock?

Glaia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Glaia's last funding round?

Glaia's most recent funding round was Seed on March 1, 2022.

Who are the main investors in Glaia?

Key investors in Glaia include Green Angel Ventures, Green Angel Syndicate.

Will Glaia IPO soon?

No public IPO plans have been announced for Glaia.

How can I track Glaia secondary market activity?

Caplight tracks bids, offers, and trades in Glaia's shares on secondary markets.

Firmographic Details

HeadquartersBristol
Employee Range10
Year Founded2019
Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?